A biopharmaceutical company that is developing antibodies to treat serious respiratory diseases and cancer. Kalobios went public earlier this year.
San Francisco, California
Inc. 5000 Rankings
No. 487 (2013)
WebsiteData as of Publication on Aug. 11, 2020